The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2022

Filed:

Oct. 14, 2019
Applicants:

Samsung Life Public Welfare Foundation, Seoul, KR;

Research & Business Foundation Sungkyunkwan University, Gyeonggi-do, KR;

Inventors:

Oh Young Bang, Seoul, KR;

Eun Hee Kim, Seoul, KR;

Jae Min Cha, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); C12N 5/0735 (2010.01); A61K 31/7105 (2006.01); C12N 5/074 (2010.01);
U.S. Cl.
CPC ...
A61K 9/1271 (2013.01); A61K 31/7105 (2013.01); C12N 5/0606 (2013.01); C12N 5/0607 (2013.01); C12N 2513/00 (2013.01);
Abstract

The present invention relates to stem cell-derived microvesicles with enhanced efficacy, a use thereof, and a method for enhancing efficacy, and more particularly, to a use of stem cell-derived microvesicles with an enhanced expression level of microRNAs for the prevention or treatment of stroke, and a method for promoting the production of microRNAs of stem cell-derived microvesicles and enhancing efficacy, and a method for promoting the production of stem cell-derived microvesicles and microRNAs within the microvesicles and enhancing the efficacy of stem cells and microvesicles thereof by 3-dimensionally culturing or ischemically stimulating stem cells. Since the method according to the present invention has excellent effects capable of promoting the production of stem cell-derived microvesicles and microRNAs in the microvesicles and capable of enhancing the efficacy of stem cells or microvesicles isolated therefrom, it is possible to obtain stem cell-derived microvesicles containing high levels of materials including therapeutic microRNAs efficiently and in large quantities through this, and thus, the microvesicles are expected to be able to be usefully used in related research fields and future clinical settings.


Find Patent Forward Citations

Loading…